Metabolic changes following eccentric exercise in trained and untrained men. 1986

W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen

The effects of one 45-min bout of high-intensity eccentric exercise (250 W) were studied in four male runners and five untrained men. Plasma creatine kinase (CK) activity in these runners was higher (P less than 0.001) than in the untrained men before exercise and peaked at 207 IU/ml 1 day after exercise, whereas in untrained men the maximum was 2,143 IU/ml 5 days after exercise. Plasma interleukin-1 (IL-1) in the trained men was also higher (P less than 0.001) than in the untrained men before exercise but did not significantly increase after exercise. In the untrained men, IL-1 was significantly elevated 3 h after exercise (P less than 0.001). In the untrained group only, 24-h urines were collected before and after exercise while the men consumed a meat-free diet. Urinary 3-methylhistidine/creatinine in the untrained group rose significantly from 127 mumol/g before exercise to 180 mumol/g 10 days after exercise. The results suggest that in untrained men eccentric exercise leads to a metabolic response indicative of delayed muscle damage. Regularly performed long distance running was associated with chronically elevated plasma IL-1 levels and serum CK activities without acute increases after an eccentric exercise bout.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008762 Methylhistidines Histidine substituted in any position with one or more methyl groups. Methylhistidine
D010807 Physical Endurance The time span between the beginning of physical activity by an individual and the termination because of exhaustion. Endurance, Physical,Physical Stamina,Stamina, Physical
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012420 Running An activity in which the body is propelled by moving the legs rapidly. Running is performed at a moderate to rapid pace and should be differentiated from JOGGING, which is performed at a much slower pace. Runnings

Related Publications

W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
February 1989, Metabolism: clinical and experimental,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
August 2000, Canadian journal of physiology and pharmacology,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
March 2008, Journal of strength and conditioning research,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
September 2011, Respiratory physiology & neurobiology,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
October 1992, Journal of applied physiology (Bethesda, Md. : 1985),
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
October 2006, Medicine and science in sports and exercise,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
February 1965, Casopis lekaru ceskych,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
February 1994, Medicine and science in sports and exercise,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
February 1998, Medicine and science in sports and exercise,
W J Evans, and C N Meredith, and J G Cannon, and C A Dinarello, and W R Frontera, and V A Hughes, and B H Jones, and H G Knuttgen
March 2010, Medicine and science in sports and exercise,
Copied contents to your clipboard!